UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005199 |
|---|---|
| Receipt number | R000006173 |
| Scientific Title | Phase II study of Bevacizumab with SOX (S-1 plus L-OHP) as second-line therapy in metastatic colorectal cancer |
| Date of disclosure of the study information | 2011/03/05 |
| Last modified on | 2011/12/19 23:03:27 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/03/05 22:48:52 | ||
| 2 | Update | 2011/12/19 23:00:21 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2011/12/19 23:03:27 | Recruitment status |
